nodes	percent_of_prediction	percent_of_DWPC	metapath
Spironolactone—ABCC2—Carboplatin—brain cancer	0.169	0.397	CbGbCtD
Spironolactone—ABCC2—Etoposide—brain cancer	0.142	0.333	CbGbCtD
Spironolactone—CYP2C8—Etoposide—brain cancer	0.0683	0.161	CbGbCtD
Spironolactone—ABCB1—Etoposide—brain cancer	0.0462	0.109	CbGbCtD
Spironolactone—Gastrointestinal symptom NOS—Hydroxyurea—brain cancer	0.00812	0.0314	CcSEcCtD
Spironolactone—Lethargy—Lomustine—brain cancer	0.0072	0.0278	CcSEcCtD
Spironolactone—Amenorrhoea—Procarbazine—brain cancer	0.00702	0.0271	CcSEcCtD
Spironolactone—Ataxia—Lomustine—brain cancer	0.00663	0.0256	CcSEcCtD
Spironolactone—SHBG—hindbrain—brain cancer	0.00624	0.0435	CbGeAlD
Spironolactone—NR3C2—hindbrain—brain cancer	0.00604	0.0421	CbGeAlD
Spironolactone—PGR—blood vessel—brain cancer	0.00589	0.0411	CbGeAlD
Spironolactone—PGR—hindbrain—brain cancer	0.00562	0.0392	CbGeAlD
Spironolactone—Gynaecomastia—Procarbazine—brain cancer	0.00552	0.0213	CcSEcCtD
Spironolactone—Amenorrhoea—Hydroxyurea—brain cancer	0.00544	0.021	CcSEcCtD
Spironolactone—Renal failure—Lomustine—brain cancer	0.00534	0.0206	CcSEcCtD
Spironolactone—Ulcer—Hydroxyurea—brain cancer	0.00505	0.0195	CcSEcCtD
Spironolactone—Lethargy—Procarbazine—brain cancer	0.00457	0.0177	CcSEcCtD
Spironolactone—CYP11B2—endocrine gland—brain cancer	0.00439	0.0306	CbGeAlD
Spironolactone—CYP11B1—endocrine gland—brain cancer	0.00439	0.0306	CbGeAlD
Spironolactone—Alopecia—Lomustine—brain cancer	0.00431	0.0167	CcSEcCtD
Spironolactone—Breast pain—Temozolomide—brain cancer	0.00428	0.0165	CcSEcCtD
Spironolactone—Amenorrhoea—Temozolomide—brain cancer	0.00425	0.0164	CcSEcCtD
Spironolactone—Ataxia—Procarbazine—brain cancer	0.00421	0.0163	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Procarbazine—brain cancer	0.00403	0.0156	CcSEcCtD
Spironolactone—Eosinophilia—Procarbazine—brain cancer	0.00383	0.0148	CcSEcCtD
Spironolactone—Leukopenia—Lomustine—brain cancer	0.0038	0.0147	CcSEcCtD
Spironolactone—Renal failure acute—Hydroxyurea—brain cancer	0.00376	0.0145	CcSEcCtD
Spironolactone—SHBG—brainstem—brain cancer	0.00357	0.0249	CbGeAlD
Spironolactone—NR3C2—brainstem—brain cancer	0.00346	0.0242	CbGeAlD
Spironolactone—Gynaecomastia—Carmustine—brain cancer	0.00345	0.0133	CcSEcCtD
Spironolactone—Drowsiness—Procarbazine—brain cancer	0.00345	0.0133	CcSEcCtD
Spironolactone—Thrombocytopenia—Lomustine—brain cancer	0.0034	0.0131	CcSEcCtD
Spironolactone—NR3C1—hindbrain—brain cancer	0.00324	0.0226	CbGeAlD
Spironolactone—Ulcer—Etoposide—brain cancer	0.00316	0.0122	CcSEcCtD
Spironolactone—Body temperature increased—Carboplatin—brain cancer	0.00313	0.0121	CcSEcCtD
Spironolactone—CYP11B1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00312	0.0184	CbGpPWpGaD
Spironolactone—NR3C2—telencephalon—brain cancer	0.00307	0.0214	CbGeAlD
Spironolactone—NR3C2—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.00287	0.017	CbGpPWpGaD
Spironolactone—CYP2C8—Xenobiotics—CYP2C9—brain cancer	0.00285	0.0168	CbGpPWpGaD
Spironolactone—CYP2C8—Tamoxifen metabolism—CYP2C9—brain cancer	0.00274	0.0162	CbGpPWpGaD
Spironolactone—Body temperature increased—Lomustine—brain cancer	0.00274	0.0106	CcSEcCtD
Spironolactone—Alopecia—Procarbazine—brain cancer	0.00274	0.0106	CcSEcCtD
Spironolactone—Drowsiness—Hydroxyurea—brain cancer	0.00267	0.0103	CcSEcCtD
Spironolactone—SHBG—gonad—brain cancer	0.00265	0.0185	CbGeAlD
Spironolactone—SLCO1A2—telencephalon—brain cancer	0.00264	0.0184	CbGeAlD
Spironolactone—Ataxia—Carmustine—brain cancer	0.00264	0.0102	CcSEcCtD
Spironolactone—SHBG—pituitary gland—brain cancer	0.00258	0.018	CbGeAlD
Spironolactone—Ataxia—Temozolomide—brain cancer	0.00255	0.00984	CcSEcCtD
Spironolactone—PGR—Ovarian Infertility Genes—ESR2—brain cancer	0.00254	0.015	CbGpPWpGaD
Spironolactone—NR3C2—pituitary gland—brain cancer	0.0025	0.0175	CbGeAlD
Spironolactone—Toxic epidermal necrolysis—Temozolomide—brain cancer	0.00244	0.00942	CcSEcCtD
Spironolactone—NR3C2—medulla oblongata—brain cancer	0.00242	0.0168	CbGeAlD
Spironolactone—Leukopenia—Procarbazine—brain cancer	0.00241	0.00933	CcSEcCtD
Spironolactone—PGR—pituitary gland—brain cancer	0.00233	0.0162	CbGeAlD
Spironolactone—AR—telencephalon—brain cancer	0.00228	0.0159	CbGeAlD
Spironolactone—Confusional state—Procarbazine—brain cancer	0.00222	0.00857	CcSEcCtD
Spironolactone—PGR—Nuclear Receptors—ESR2—brain cancer	0.00221	0.0131	CbGpPWpGaD
Spironolactone—NR3C2—midbrain—brain cancer	0.00221	0.0154	CbGeAlD
Spironolactone—Vomiting—Lomustine—brain cancer	0.0022	0.00852	CcSEcCtD
Spironolactone—Erectile dysfunction—Temozolomide—brain cancer	0.00216	0.00833	CcSEcCtD
Spironolactone—Thrombocytopenia—Procarbazine—brain cancer	0.00216	0.00833	CcSEcCtD
Spironolactone—NR3C2—spinal cord—brain cancer	0.00215	0.015	CbGeAlD
Spironolactone—AR—Notch-mediated HES/HEY network—HEY1—brain cancer	0.00213	0.0126	CbGpPWpGaD
Spironolactone—Renal failure—Carmustine—brain cancer	0.00212	0.0082	CcSEcCtD
Spironolactone—Alopecia—Hydroxyurea—brain cancer	0.00212	0.00819	CcSEcCtD
Spironolactone—SLCO1A2—medulla oblongata—brain cancer	0.00207	0.0144	CbGeAlD
Spironolactone—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.00207	0.00799	CcSEcCtD
Spironolactone—Nausea—Lomustine—brain cancer	0.00206	0.00796	CcSEcCtD
Spironolactone—SHBG—endocrine gland—brain cancer	0.002	0.014	CbGeAlD
Spironolactone—Somnolence—Procarbazine—brain cancer	0.00196	0.00756	CcSEcCtD
Spironolactone—Cramp muscle—Etoposide—brain cancer	0.00195	0.00754	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Etoposide—brain cancer	0.00195	0.00754	CcSEcCtD
Spironolactone—NR3C2—endocrine gland—brain cancer	0.00194	0.0135	CbGeAlD
Spironolactone—Ill-defined disorder—Hydroxyurea—brain cancer	0.00194	0.00748	CcSEcCtD
Spironolactone—CYP11B2—Biological oxidations—CYP2C9—brain cancer	0.00192	0.0113	CbGpPWpGaD
Spironolactone—NR3C2—head—brain cancer	0.00191	0.0133	CbGeAlD
Spironolactone—AR—gonad—brain cancer	0.0019	0.0132	CbGeAlD
Spironolactone—CYP11B2—Metapathway biotransformation—CYP2C9—brain cancer	0.00189	0.0112	CbGpPWpGaD
Spironolactone—SLCO1A2—midbrain—brain cancer	0.00189	0.0132	CbGeAlD
Spironolactone—Malaise—Hydroxyurea—brain cancer	0.00188	0.00727	CcSEcCtD
Spironolactone—AR—FOXA1 transcription factor network—SHH—brain cancer	0.00188	0.0111	CbGpPWpGaD
Spironolactone—Leukopenia—Hydroxyurea—brain cancer	0.00187	0.00722	CcSEcCtD
Spironolactone—ABCC2—Irinotecan Pathway—APC—brain cancer	0.00186	0.011	CbGpPWpGaD
Spironolactone—NR3C1—brainstem—brain cancer	0.00186	0.013	CbGeAlD
Spironolactone—AR—pituitary gland—brain cancer	0.00185	0.0129	CbGeAlD
Spironolactone—SLCO1A2—spinal cord—brain cancer	0.00185	0.0129	CbGeAlD
Spironolactone—ABCB1—blood vessel—brain cancer	0.00182	0.0127	CbGeAlD
Spironolactone—Feeling abnormal—Procarbazine—brain cancer	0.00181	0.00701	CcSEcCtD
Spironolactone—SHBG—central nervous system—brain cancer	0.0018	0.0126	CbGeAlD
Spironolactone—PGR—endocrine gland—brain cancer	0.0018	0.0126	CbGeAlD
Spironolactone—PGR—head—brain cancer	0.00178	0.0124	CbGeAlD
Spironolactone—Erythema multiforme—Temozolomide—brain cancer	0.00177	0.00684	CcSEcCtD
Spironolactone—SHBG—cerebellum—brain cancer	0.00176	0.0123	CbGeAlD
Spironolactone—Discomfort—Hydroxyurea—brain cancer	0.00176	0.00678	CcSEcCtD
Spironolactone—PGR—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.00175	0.0103	CbGpPWpGaD
Spironolactone—Urticaria—Procarbazine—brain cancer	0.00175	0.00676	CcSEcCtD
Spironolactone—NR3C2—central nervous system—brain cancer	0.00175	0.0122	CbGeAlD
Spironolactone—Body temperature increased—Procarbazine—brain cancer	0.00174	0.00672	CcSEcCtD
Spironolactone—Alopecia—Carmustine—brain cancer	0.00171	0.00662	CcSEcCtD
Spironolactone—NR3C2—cerebellum—brain cancer	0.00171	0.0119	CbGeAlD
Spironolactone—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00171	0.0101	CbGpPWpGaD
Spironolactone—AR—Nuclear Receptors—ESR2—brain cancer	0.00169	0.00996	CbGpPWpGaD
Spironolactone—Thrombocytopenia—Hydroxyurea—brain cancer	0.00167	0.00644	CcSEcCtD
Spironolactone—SLCO1A2—endocrine gland—brain cancer	0.00166	0.0116	CbGeAlD
Spironolactone—Stevens-Johnson syndrome—Etoposide—brain cancer	0.00166	0.00639	CcSEcCtD
Spironolactone—Alopecia—Temozolomide—brain cancer	0.00166	0.00639	CcSEcCtD
Spironolactone—CYP11B1—Biological oxidations—CYP2C9—brain cancer	0.00166	0.00977	CbGpPWpGaD
Spironolactone—NR3C1—telencephalon—brain cancer	0.00165	0.0115	CbGeAlD
Spironolactone—Renal failure—Etoposide—brain cancer	0.00164	0.00634	CcSEcCtD
Spironolactone—SLCO1A2—head—brain cancer	0.00164	0.0114	CbGeAlD
Spironolactone—CYP11B1—Metapathway biotransformation—CYP2C9—brain cancer	0.00163	0.00964	CbGpPWpGaD
Spironolactone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00163	0.00959	CbGpPWpGaD
Spironolactone—PGR—central nervous system—brain cancer	0.00162	0.0113	CbGeAlD
Spironolactone—Hypersensitivity—Procarbazine—brain cancer	0.00162	0.00626	CcSEcCtD
Spironolactone—AR—spinal cord—brain cancer	0.0016	0.0111	CbGeAlD
Spironolactone—PGR—cerebellum—brain cancer	0.00159	0.0111	CbGeAlD
Spironolactone—Agranulocytosis—Etoposide—brain cancer	0.00156	0.00602	CcSEcCtD
Spironolactone—Pruritus—Procarbazine—brain cancer	0.00156	0.00602	CcSEcCtD
Spironolactone—ABCC2—endocrine gland—brain cancer	0.00155	0.0108	CbGeAlD
Spironolactone—PGR—Ovarian Infertility Genes—CDK4—brain cancer	0.00155	0.00913	CbGpPWpGaD
Spironolactone—Somnolence—Hydroxyurea—brain cancer	0.00151	0.00585	CcSEcCtD
Spironolactone—Ill-defined disorder—Temozolomide—brain cancer	0.00151	0.00584	CcSEcCtD
Spironolactone—Leukopenia—Carmustine—brain cancer	0.00151	0.00583	CcSEcCtD
Spironolactone—Diarrhoea—Procarbazine—brain cancer	0.00151	0.00582	CcSEcCtD
Spironolactone—CYP2C8—pituitary gland—brain cancer	0.0015	0.0105	CbGeAlD
Spironolactone—SLCO1A2—central nervous system—brain cancer	0.0015	0.0104	CbGeAlD
Spironolactone—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00147	0.00568	CcSEcCtD
Spironolactone—Malaise—Temozolomide—brain cancer	0.00147	0.00568	CcSEcCtD
Spironolactone—SLCO1A2—cerebellum—brain cancer	0.00146	0.0102	CbGeAlD
Spironolactone—Leukopenia—Temozolomide—brain cancer	0.00146	0.00564	CcSEcCtD
Spironolactone—PGR—Validated nuclear estrogen receptor alpha network—ESR2—brain cancer	0.00146	0.00861	CbGpPWpGaD
Spironolactone—Dizziness—Procarbazine—brain cancer	0.00146	0.00562	CcSEcCtD
Spironolactone—AR—endocrine gland—brain cancer	0.00144	0.01	CbGeAlD
Spironolactone—SHBG—brain—brain cancer	0.00143	0.00998	CbGeAlD
Spironolactone—AR—head—brain cancer	0.00142	0.00988	CbGeAlD
Spironolactone—Erythema multiforme—Etoposide—brain cancer	0.00142	0.00547	CcSEcCtD
Spironolactone—Feeling abnormal—Hydroxyurea—brain cancer	0.0014	0.00542	CcSEcCtD
Spironolactone—Vomiting—Procarbazine—brain cancer	0.0014	0.00541	CcSEcCtD
Spironolactone—Confusional state—Carmustine—brain cancer	0.00139	0.00536	CcSEcCtD
Spironolactone—Rash—Procarbazine—brain cancer	0.00139	0.00536	CcSEcCtD
Spironolactone—NR3C2—brain—brain cancer	0.00139	0.00967	CbGeAlD
Spironolactone—Dermatitis—Procarbazine—brain cancer	0.00139	0.00536	CcSEcCtD
Spironolactone—Medroxyprogesterone Acetate—CYP2C9—brain cancer	0.00138	0.471	CrCbGaD
Spironolactone—Headache—Procarbazine—brain cancer	0.00138	0.00533	CcSEcCtD
Spironolactone—NR3C1—gonad—brain cancer	0.00138	0.0096	CbGeAlD
Spironolactone—Discomfort—Temozolomide—brain cancer	0.00137	0.0053	CcSEcCtD
Spironolactone—CYP2C8—Arachidonic acid metabolism—CYP2C9—brain cancer	0.00137	0.00809	CbGpPWpGaD
Spironolactone—Thrombocytopenia—Carmustine—brain cancer	0.00135	0.00521	CcSEcCtD
Spironolactone—Body temperature increased—Hydroxyurea—brain cancer	0.00135	0.0052	CcSEcCtD
Spironolactone—NR3C1—pituitary gland—brain cancer	0.00134	0.00936	CbGeAlD
Spironolactone—Confusional state—Temozolomide—brain cancer	0.00134	0.00518	CcSEcCtD
Spironolactone—AR—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.00133	0.00787	CbGpPWpGaD
Spironolactone—Anaphylactic shock—Temozolomide—brain cancer	0.00133	0.00514	CcSEcCtD
Spironolactone—Alopecia—Etoposide—brain cancer	0.00132	0.00512	CcSEcCtD
Spironolactone—Nausea—Procarbazine—brain cancer	0.00131	0.00505	CcSEcCtD
Spironolactone—Thrombocytopenia—Temozolomide—brain cancer	0.0013	0.00503	CcSEcCtD
Spironolactone—NR3C1—medulla oblongata—brain cancer	0.0013	0.00903	CbGeAlD
Spironolactone—AR—central nervous system—brain cancer	0.00129	0.00902	CbGeAlD
Spironolactone—PGR—brain—brain cancer	0.00129	0.00899	CbGeAlD
Spironolactone—NR3C1—Transcription factor regulation in adipogenesis—IRS2—brain cancer	0.00129	0.00759	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—HES5—brain cancer	0.00128	0.00756	CbGpPWpGaD
Spironolactone—NR3C1—Nuclear Receptors—ESR2—brain cancer	0.00128	0.00755	CbGpPWpGaD
Spironolactone—Hypersensitivity—Hydroxyurea—brain cancer	0.00126	0.00485	CcSEcCtD
Spironolactone—Muscle spasms—Etoposide—brain cancer	0.00125	0.00485	CcSEcCtD
Spironolactone—Somnolence—Carmustine—brain cancer	0.00122	0.00473	CcSEcCtD
Spironolactone—AR—Coregulation of Androgen receptor activity—CDK6—brain cancer	0.00122	0.0072	CbGpPWpGaD
Spironolactone—Ill-defined disorder—Etoposide—brain cancer	0.00121	0.00468	CcSEcCtD
Spironolactone—SLCO1A2—brain—brain cancer	0.00119	0.00829	CbGeAlD
Spironolactone—Gastrointestinal disorder—Carmustine—brain cancer	0.00119	0.00459	CcSEcCtD
Spironolactone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00118	0.00699	CbGpPWpGaD
Spironolactone—NR3C1—midbrain—brain cancer	0.00118	0.00826	CbGeAlD
Spironolactone—Somnolence—Temozolomide—brain cancer	0.00118	0.00457	CcSEcCtD
Spironolactone—Malaise—Etoposide—brain cancer	0.00118	0.00455	CcSEcCtD
Spironolactone—CYP2C8—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00117	0.0069	CbGpPWpGaD
Spironolactone—Leukopenia—Etoposide—brain cancer	0.00117	0.00451	CcSEcCtD
Spironolactone—Diarrhoea—Hydroxyurea—brain cancer	0.00117	0.0045	CcSEcCtD
Spironolactone—CYP2C8—endocrine gland—brain cancer	0.00116	0.0081	CbGeAlD
Spironolactone—NR3C1—spinal cord—brain cancer	0.00116	0.00806	CbGeAlD
Spironolactone—PGR—Signaling by ERBB4—GFAP—brain cancer	0.00115	0.00682	CbGpPWpGaD
Spironolactone—Gastrointestinal disorder—Temozolomide—brain cancer	0.00115	0.00444	CcSEcCtD
Spironolactone—Feeling abnormal—Carmustine—brain cancer	0.00114	0.00438	CcSEcCtD
Spironolactone—Dizziness—Hydroxyurea—brain cancer	0.00113	0.00435	CcSEcCtD
Spironolactone—AR—Notch-mediated HES/HEY network—HES1—brain cancer	0.00111	0.00652	CbGpPWpGaD
Spironolactone—Discomfort—Etoposide—brain cancer	0.0011	0.00424	CcSEcCtD
Spironolactone—Feeling abnormal—Temozolomide—brain cancer	0.0011	0.00424	CcSEcCtD
Spironolactone—Body temperature increased—Carmustine—brain cancer	0.00109	0.00421	CcSEcCtD
Spironolactone—Vomiting—Hydroxyurea—brain cancer	0.00108	0.00418	CcSEcCtD
Spironolactone—Rash—Hydroxyurea—brain cancer	0.00107	0.00415	CcSEcCtD
Spironolactone—Confusional state—Etoposide—brain cancer	0.00107	0.00415	CcSEcCtD
Spironolactone—Dermatitis—Hydroxyurea—brain cancer	0.00107	0.00415	CcSEcCtD
Spironolactone—Headache—Hydroxyurea—brain cancer	0.00107	0.00412	CcSEcCtD
Spironolactone—Anaphylactic shock—Etoposide—brain cancer	0.00107	0.00411	CcSEcCtD
Spironolactone—Urticaria—Temozolomide—brain cancer	0.00106	0.00408	CcSEcCtD
Spironolactone—Body temperature increased—Temozolomide—brain cancer	0.00105	0.00406	CcSEcCtD
Spironolactone—Thrombocytopenia—Etoposide—brain cancer	0.00104	0.00403	CcSEcCtD
Spironolactone—AR—Regulation of Androgen receptor activity—SIRT1—brain cancer	0.00104	0.00615	CbGpPWpGaD
Spironolactone—NR3C1—endocrine gland—brain cancer	0.00104	0.00725	CbGeAlD
Spironolactone—PGR—Validated nuclear estrogen receptor alpha network—PCNA—brain cancer	0.00103	0.00607	CbGpPWpGaD
Spironolactone—AR—brain—brain cancer	0.00103	0.00716	CbGeAlD
Spironolactone—NR3C1—head—brain cancer	0.00103	0.00716	CbGeAlD
Spironolactone—Hypersensitivity—Carmustine—brain cancer	0.00101	0.00392	CcSEcCtD
Spironolactone—Nausea—Hydroxyurea—brain cancer	0.00101	0.00391	CcSEcCtD
Spironolactone—NR3C1—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.00101	0.00597	CbGpPWpGaD
Spironolactone—Hypersensitivity—Temozolomide—brain cancer	0.000981	0.00379	CcSEcCtD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—HES5—brain cancer	0.000972	0.00573	CbGpPWpGaD
Spironolactone—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00096	0.00567	CbGpPWpGaD
Spironolactone—Somnolence—Etoposide—brain cancer	0.000947	0.00366	CcSEcCtD
Spironolactone—Diarrhoea—Carmustine—brain cancer	0.000942	0.00364	CcSEcCtD
Spironolactone—Pruritus—Temozolomide—brain cancer	0.000942	0.00364	CcSEcCtD
Spironolactone—NR3C1—central nervous system—brain cancer	0.000937	0.00653	CbGeAlD
Spironolactone—Gastrointestinal disorder—Etoposide—brain cancer	0.00092	0.00355	CcSEcCtD
Spironolactone—NR3C1—cerebellum—brain cancer	0.000916	0.00639	CbGeAlD
Spironolactone—Dizziness—Carmustine—brain cancer	0.000911	0.00352	CcSEcCtD
Spironolactone—Diarrhoea—Temozolomide—brain cancer	0.000911	0.00352	CcSEcCtD
Spironolactone—ABCB1—telencephalon—brain cancer	0.000883	0.00615	CbGeAlD
Spironolactone—Dizziness—Temozolomide—brain cancer	0.00088	0.0034	CcSEcCtD
Spironolactone—Feeling abnormal—Etoposide—brain cancer	0.000878	0.00339	CcSEcCtD
Spironolactone—Vomiting—Carmustine—brain cancer	0.000876	0.00338	CcSEcCtD
Spironolactone—Rash—Carmustine—brain cancer	0.000868	0.00335	CcSEcCtD
Spironolactone—Dermatitis—Carmustine—brain cancer	0.000868	0.00335	CcSEcCtD
Spironolactone—Headache—Carmustine—brain cancer	0.000863	0.00333	CcSEcCtD
Spironolactone—Vomiting—Temozolomide—brain cancer	0.000846	0.00327	CcSEcCtD
Spironolactone—Urticaria—Etoposide—brain cancer	0.000846	0.00327	CcSEcCtD
Spironolactone—Body temperature increased—Etoposide—brain cancer	0.000842	0.00325	CcSEcCtD
Spironolactone—Rash—Temozolomide—brain cancer	0.000839	0.00324	CcSEcCtD
Spironolactone—Dermatitis—Temozolomide—brain cancer	0.000839	0.00324	CcSEcCtD
Spironolactone—Headache—Temozolomide—brain cancer	0.000834	0.00322	CcSEcCtD
Spironolactone—CYP2C8—brain—brain cancer	0.000831	0.00579	CbGeAlD
Spironolactone—Nausea—Carmustine—brain cancer	0.000818	0.00316	CcSEcCtD
Spironolactone—Progesterone—CYP2C9—brain cancer	0.000798	0.272	CrCbGaD
Spironolactone—Nausea—Temozolomide—brain cancer	0.000791	0.00305	CcSEcCtD
Spironolactone—NR3C1—Regulation of Androgen receptor activity—SIRT1—brain cancer	0.00079	0.00466	CbGpPWpGaD
Spironolactone—Hypersensitivity—Etoposide—brain cancer	0.000785	0.00303	CcSEcCtD
Spironolactone—Testosterone—CYP2C9—brain cancer	0.000755	0.257	CrCbGaD
Spironolactone—Pruritus—Etoposide—brain cancer	0.000754	0.00291	CcSEcCtD
Spironolactone—NR3C1—brain—brain cancer	0.000744	0.00519	CbGeAlD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000738	0.00435	CbGpPWpGaD
Spironolactone—ABCB1—gonad—brain cancer	0.000737	0.00514	CbGeAlD
Spironolactone—Diarrhoea—Etoposide—brain cancer	0.000729	0.00281	CcSEcCtD
Spironolactone—ABCB1—pituitary gland—brain cancer	0.000719	0.00501	CbGeAlD
Spironolactone—Dizziness—Etoposide—brain cancer	0.000704	0.00272	CcSEcCtD
Spironolactone—ABCB1—medulla oblongata—brain cancer	0.000694	0.00484	CbGeAlD
Spironolactone—AR—Androgen receptor signaling pathway—SIRT1—brain cancer	0.000688	0.00406	CbGpPWpGaD
Spironolactone—AR—Androgen receptor signaling pathway—CCNE1—brain cancer	0.000679	0.00401	CbGpPWpGaD
Spironolactone—Vomiting—Etoposide—brain cancer	0.000677	0.00262	CcSEcCtD
Spironolactone—Rash—Etoposide—brain cancer	0.000672	0.00259	CcSEcCtD
Spironolactone—Dermatitis—Etoposide—brain cancer	0.000671	0.00259	CcSEcCtD
Spironolactone—Headache—Etoposide—brain cancer	0.000667	0.00258	CcSEcCtD
Spironolactone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.000665	0.00392	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—VAV1—brain cancer	0.00066	0.00389	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000636	0.00375	CbGpPWpGaD
Spironolactone—ABCB1—midbrain—brain cancer	0.000634	0.00442	CbGeAlD
Spironolactone—Nausea—Etoposide—brain cancer	0.000633	0.00244	CcSEcCtD
Spironolactone—ABCB1—spinal cord—brain cancer	0.000619	0.00431	CbGeAlD
Spironolactone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000592	0.0035	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000579	0.00342	CbGpPWpGaD
Spironolactone—PGR—Validated nuclear estrogen receptor alpha network—CCND1—brain cancer	0.000574	0.00339	CbGpPWpGaD
Spironolactone—CYP11B1—Corticotropin-releasing hormone—RELA—brain cancer	0.000566	0.00334	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear SMAD2/3 signaling—CDK4—brain cancer	0.000561	0.00331	CbGpPWpGaD
Spironolactone—ABCB1—endocrine gland—brain cancer	0.000557	0.00388	CbGeAlD
Spironolactone—ABCB1—head—brain cancer	0.00055	0.00383	CbGeAlD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000549	0.00324	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000545	0.00322	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—PDGFRA—brain cancer	0.00054	0.00319	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000539	0.00318	CbGpPWpGaD
Spironolactone—AR—Coregulation of Androgen receptor activity—CDKN2A—brain cancer	0.000538	0.00317	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—APC—brain cancer	0.000533	0.00315	CbGpPWpGaD
Spironolactone—CYP2C8—Biological oxidations—CYP2C9—brain cancer	0.00051	0.00301	CbGpPWpGaD
Spironolactone—CYP11B1—Corticotropin-releasing hormone—IL2—brain cancer	0.000509	0.00301	CbGpPWpGaD
Spironolactone—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	0.000503	0.00297	CbGpPWpGaD
Spironolactone—ABCB1—central nervous system—brain cancer	0.000502	0.0035	CbGeAlD
Spironolactone—NR3C2—Generic Transcription Pathway—ESR2—brain cancer	0.000496	0.00293	CbGpPWpGaD
Spironolactone—CYP11B1—Corticotropin-releasing hormone—CTNNB1—brain cancer	0.000492	0.0029	CbGpPWpGaD
Spironolactone—ABCB1—cerebellum—brain cancer	0.00049	0.00342	CbGeAlD
Spironolactone—AR—Notch-mediated HES/HEY network—STAT3—brain cancer	0.000483	0.00285	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—IRS2—brain cancer	0.000474	0.0028	CbGpPWpGaD
Spironolactone—NR3C2—Generic Transcription Pathway—NOTCH2—brain cancer	0.00047	0.00277	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000465	0.00274	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000464	0.00274	CbGpPWpGaD
Spironolactone—NR3C1—Endoderm Differentiation—APC—brain cancer	0.000461	0.00272	CbGpPWpGaD
Spironolactone—PGR—Validated nuclear estrogen receptor alpha network—MYC—brain cancer	0.00046	0.00272	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—BRCA2—brain cancer	0.000459	0.00271	CbGpPWpGaD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—S100A10—brain cancer	0.000457	0.0027	CbGpPWpGaD
Spironolactone—AR—Coregulation of Androgen receptor activity—CCND1—brain cancer	0.000454	0.00268	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—SIRT1—brain cancer	0.000451	0.00266	CbGpPWpGaD
Spironolactone—AR—Coregulation of Androgen receptor activity—CTNNB1—brain cancer	0.00045	0.00266	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—brain cancer	0.000433	0.00256	CbGpPWpGaD
Spironolactone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—brain cancer	0.000425	0.00251	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—HES1—brain cancer	0.000423	0.0025	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—S100A10—brain cancer	0.000416	0.00246	CbGpPWpGaD
Spironolactone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	0.000415	0.00245	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000414	0.00244	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000399	0.00235	CbGpPWpGaD
Spironolactone—ABCB1—brain—brain cancer	0.000398	0.00278	CbGeAlD
Spironolactone—AR—Androgen receptor signaling pathway—RELA—brain cancer	0.000383	0.00226	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000381	0.00225	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.000373	0.0022	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.000369	0.00218	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—brain cancer	0.000366	0.00216	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—CDKN2A—brain cancer	0.000366	0.00216	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—brain cancer	0.000362	0.00214	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—OR4C12—brain cancer	0.000356	0.0021	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—OR14C36—brain cancer	0.000356	0.0021	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.000343	0.00202	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—CDK4—brain cancer	0.000341	0.00201	CbGpPWpGaD
Spironolactone—AR—Androgen receptor signaling pathway—CCND1—brain cancer	0.000336	0.00198	CbGpPWpGaD
Spironolactone—AR—Androgen receptor signaling pathway—CTNNB1—brain cancer	0.000333	0.00196	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—CYP2C9—brain cancer	0.000328	0.00194	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.000327	0.00193	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—ERBB2—brain cancer	0.000325	0.00192	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—HES1—brain cancer	0.000321	0.0019	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—IL2—brain cancer	0.000317	0.00187	CbGpPWpGaD
Spironolactone—NR3C1—Endoderm Differentiation—CTNNB1—brain cancer	0.000313	0.00185	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—IRS2—brain cancer	0.000311	0.00183	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—RELA—brain cancer	0.00031	0.00183	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—CCND1—brain cancer	0.000309	0.00182	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—CTNNB1—brain cancer	0.000306	0.0018	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—DTX2—brain cancer	0.000303	0.00179	CbGpPWpGaD
Spironolactone—PGR—Generic Transcription Pathway—ESR2—brain cancer	0.000302	0.00178	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—brain cancer	0.000293	0.00173	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000291	0.00172	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—brain cancer	0.000291	0.00171	CbGpPWpGaD
Spironolactone—AR—Androgen receptor signaling pathway—STAT3—brain cancer	0.00029	0.00171	CbGpPWpGaD
Spironolactone—PGR—Generic Transcription Pathway—NOTCH2—brain cancer	0.000286	0.00169	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—PDGFRA—brain cancer	0.000283	0.00167	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—CYP2C9—brain cancer	0.000283	0.00167	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.000282	0.00167	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—BSG—brain cancer	0.000279	0.00165	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—IL2—brain cancer	0.000279	0.00165	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—DNMT1—brain cancer	0.000266	0.00157	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.000266	0.00157	CbGpPWpGaD
Spironolactone—AR—Androgen receptor signaling pathway—EGFR—brain cancer	0.000264	0.00156	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—MYC—brain cancer	0.000248	0.00146	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—BSG—brain cancer	0.000241	0.00142	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—IDH1—brain cancer	0.00024	0.00142	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—ESR2—brain cancer	0.000239	0.00141	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000236	0.00139	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—ESR2—brain cancer	0.00023	0.00136	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PTCH2—brain cancer	0.00023	0.00135	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—NOTCH2—brain cancer	0.000226	0.00134	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—EGFR—brain cancer	0.000225	0.00133	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000224	0.00132	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—HES5—brain cancer	0.000222	0.00131	CbGpPWpGaD
Spironolactone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—brain cancer	0.00022	0.0013	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—CCND1—brain cancer	0.00022	0.0013	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—NOTCH2—brain cancer	0.000218	0.00129	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	0.000218	0.00129	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—STRADA—brain cancer	0.000216	0.00127	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—CTNNB1—brain cancer	0.000212	0.00125	CbGpPWpGaD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000211	0.00125	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—IDH1—brain cancer	0.000207	0.00122	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	0.000206	0.00122	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—TP53—brain cancer	0.000203	0.0012	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000196	0.00116	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000196	0.00116	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000196	0.00115	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—SIRT1—brain cancer	0.000192	0.00114	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000192	0.00113	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—VEGFA—brain cancer	0.000192	0.00113	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—ENO2—brain cancer	0.00019	0.00112	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000189	0.00112	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—VEGFA—brain cancer	0.000187	0.0011	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—CTNNB1—brain cancer	0.000186	0.0011	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	0.000182	0.00108	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	0.000181	0.00107	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—ABR—brain cancer	0.00018	0.00106	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—TP53—brain cancer	0.000179	0.00106	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CYP2C9—brain cancer	0.000177	0.00105	CbGpPWpGaD
Spironolactone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	0.000177	0.00104	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—MYC—brain cancer	0.000177	0.00104	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—ESR2—brain cancer	0.000175	0.00103	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—GLI2—brain cancer	0.000174	0.00103	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—EGFR—brain cancer	0.000173	0.00102	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000169	0.000995	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—NOTCH2—brain cancer	0.000165	0.000977	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—ENO2—brain cancer	0.000164	0.000966	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—GLI1—brain cancer	0.000164	0.000965	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—STAT3—brain cancer	0.000162	0.000959	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—DNMT1—brain cancer	0.000162	0.000957	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—brain cancer	0.000161	0.000951	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	0.000159	0.000938	CbGpPWpGaD
Spironolactone—NR3C2—Generic Transcription Pathway—MYC—brain cancer	0.000157	0.000924	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000155	0.000916	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—SUFU—brain cancer	0.000155	0.000915	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—IL2—brain cancer	0.000154	0.000912	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.000152	0.000898	CbGpPWpGaD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	0.000152	0.000895	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—BSG—brain cancer	0.000151	0.000891	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.00015	0.000887	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—GFAP—brain cancer	0.00015	0.000883	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	0.000146	0.000863	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—ESR2—brain cancer	0.000146	0.000859	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—TP53—brain cancer	0.000145	0.000856	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000143	0.000845	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	0.000143	0.000844	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—HEY1—brain cancer	0.000142	0.000837	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—VEGFA—brain cancer	0.000142	0.000837	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.00014	0.000825	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—DLL1—brain cancer	0.000139	0.000821	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—NOTCH2—brain cancer	0.000138	0.000814	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.000133	0.000786	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—VEGFA—brain cancer	0.000131	0.000775	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—IDH1—brain cancer	0.00013	0.000766	CbGpPWpGaD
Spironolactone—AR—Gene Expression—DNMT1—brain cancer	0.000124	0.000729	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	0.00012	0.000709	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—SHH—brain cancer	0.000118	0.000698	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—SIRT1—brain cancer	0.000117	0.000692	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.000115	0.000679	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TRPC6—brain cancer	0.000114	0.000673	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—SMO—brain cancer	0.000112	0.000662	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PTCH1—brain cancer	0.000112	0.000662	CbGpPWpGaD
Spironolactone—AR—Gene Expression—ESR2—brain cancer	0.000111	0.000654	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.000108	0.000639	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000106	0.000624	CbGpPWpGaD
Spironolactone—AR—Gene Expression—NOTCH2—brain cancer	0.000105	0.00062	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—ENO2—brain cancer	0.000103	0.000605	CbGpPWpGaD
Spironolactone—PGR—Generic Transcription Pathway—MYC—brain cancer	9.54e-05	0.000563	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—DNMT1—brain cancer	9.37e-05	0.000553	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	9.04e-05	0.000534	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NOTCH2—brain cancer	8.96e-05	0.000529	CbGpPWpGaD
Spironolactone—AR—Gene Expression—SIRT1—brain cancer	8.93e-05	0.000527	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP2C9—brain cancer	8.72e-05	0.000515	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PIK3CG—brain cancer	8.71e-05	0.000514	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—VAV1—brain cancer	8.54e-05	0.000504	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—ESR2—brain cancer	8.41e-05	0.000496	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	8.41e-05	0.000496	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—NOTCH2—brain cancer	7.97e-05	0.00047	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP2C9—brain cancer	7.6e-05	0.000448	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—MYC—brain cancer	7.54e-05	0.000445	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PIK3CG—brain cancer	7.51e-05	0.000443	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	7.43e-05	0.000439	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—BSG—brain cancer	7.42e-05	0.000438	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	7.36e-05	0.000434	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—HES1—brain cancer	7.35e-05	0.000434	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—MYC—brain cancer	7.27e-05	0.000429	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PDGFRA—brain cancer	7e-05	0.000413	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—SPP1—brain cancer	6.79e-05	0.000401	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—SIRT1—brain cancer	6.77e-05	0.0004	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	6.48e-05	0.000382	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—BSG—brain cancer	6.46e-05	0.000381	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—IDH1—brain cancer	6.38e-05	0.000376	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IRS2—brain cancer	6.14e-05	0.000363	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	5.96e-05	0.000352	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	5.83e-05	0.000344	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—IDH1—brain cancer	5.56e-05	0.000328	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—MYC—brain cancer	5.51e-05	0.000325	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—APC—brain cancer	5.42e-05	0.00032	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PIK3CG—brain cancer	5.42e-05	0.00032	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	5.19e-05	0.000306	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ENO2—brain cancer	5.04e-05	0.000298	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	4.9e-05	0.000289	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PIK3CG—brain cancer	4.71e-05	0.000278	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—MYC—brain cancer	4.59e-05	0.000271	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ENO2—brain cancer	4.39e-05	0.000259	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—RELA—brain cancer	4.24e-05	0.00025	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—ERBB2—brain cancer	4.21e-05	0.000249	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IL2—brain cancer	3.82e-05	0.000225	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CCND1—brain cancer	3.72e-05	0.00022	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CTNNB1—brain cancer	3.69e-05	0.000218	CbGpPWpGaD
Spironolactone—AR—Gene Expression—MYC—brain cancer	3.5e-05	0.000206	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—VEGFA—brain cancer	3.24e-05	0.000191	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—STAT3—brain cancer	3.21e-05	0.00019	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MYC—brain cancer	2.99e-05	0.000176	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—EGFR—brain cancer	2.92e-05	0.000172	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—MYC—brain cancer	2.65e-05	0.000157	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TP53—brain cancer	2.45e-05	0.000145	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PIK3CG—brain cancer	2.31e-05	0.000136	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PIK3CG—brain cancer	2.01e-05	0.000119	CbGpPWpGaD
